Yearly zoledronic acid non-inferior to daily bisphosponates
17 April 2009
| by Nicola Garrett
A single annual infusion of zoledronic acid is at least as effective as a daily oral bisphosponates at preventing and treating glucocorticoid- induced osteoporosis, according to the latest findings from the HORIZON study. ...
Want to read complete article? Please Sign in or Register.